Fennec Pharma Cash Flow - Annual (NASDAQ:FENC)

Add to My Stocks
$8.17 $0.06 (0.73%) FENC stock closing price Sep 20, 2018 (Closing)

For analyzing any company like Fennec Pharma from an investment perspective, its important to check the cash flow statement. In simple terms, the cash flow statement measures the cash that has come into the company, and the cash that has gone out during a given period, while the other statements, the income statement and balance sheet, give details about Fennec Pharma profits and Fennec Pharma debt. Fennec Pharma saw a cash impact of $27.97M from the issuance of FENC shares. The cash flow statement helps in the Fennec Pharma stock analysis by providing more information for evaluating changes in assets, liabilities and equities. FENC decrease in investments stood at a value of $- for the latest year 2017.

View details of Fennec Pharma cash flows for latest & last 10 financial years
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Jan - Dec2017201620152014201320122011201020092008
Net Income Cash Flow
-7.04M-2.78M-0.65M-2.17M1.84M-5.16M4.68M-7.82M-3.01M-13.6M
Depreciation Depletion Amortization Cash-Flow---------0.53M-
Net Increase (Decrease) in Assets Liabilities1.01M--0.06M--0.36M--0.08M--1.88M-
Cash From (used in) Discontinued Operations----------
Other Adjustments Net2.39M--1.14M--3.69M1.88M-7.83M5.77M-2.5M
Net Cash from (used by) Operating Activities
-3.64M-2.12M-1.86M-1.69M-2.21M-2.99M-3.22M-1.92M-4.68M-10.8M
Increase (Decrease) in Prop Plant And Equipment----------0.01M
Acquisition Disposition of Subsidiaires----------
Increase (Decrease) in Investments----------
Other Cash Inflow (Outflow) from Investment Activities----------
Net Cash from (used by) Investment Activities
----------0.01M
Issuance (Purchase) of Equity Shares27.97M5.1M-2.34M1.57M-2.56M7.19M--
Issuance (Repayment) of Debt Securities----------
Increase (Decrease) in Bank & Other Borrowings----------
Payment of Dividends & Other Cash Distributions----------
Other Cash from (used by) Financing Activities----------
Net Cash from (used by) Financing Activities
27.97M5.1M-2.34M1.57M-2.56M7.19M--
Effect of Exchange Rate Changes on Cash----------
Net Change in Cash & Cash Equivalents
24.33M2.98M-1.36M--0.64M-2.99M-0.65M5.26M-4.66M-10.81M
Cash & Equivalents at Beginning of Year3.92M-2.3M1.66M2.3M5.29M5.94M-5.34M16.16M
Cash & Equivalents at Year End28.26M3.92M-2.3M1.66M2.3M5.29M5.94M-5.34M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Fennec Pharma stock price history provides insight into historical stock price fluctuations, and Fennec Pharma stock comparison chart enables peer comparison. Some of the key terms used in the statement of cash flows are:

  • Net Change in Cash and Cash Equivalents: A positive net change in cash and cash equivalents shows that Fennec Pharma is able to meet its expenditure and grow cash at hand which demonstrates the financial strength of the company's balance sheet. Also see - Fennec Pharma stock price movement.
  • Cash Flow from operating activities: This is the cash that the company receives from ongoing operations. Fennec Pharma lost $-3.64M cash from operations. It is important to check this to see where the company is getting its money from.
  • Cash from investing stood at a negative value of $- for FENC stock. A company with surplus cash usually thinks of re-investing it in the form of buying fixed assests, or purchasing plant/ machinery which will help grow the business further. By looking at cash flow from investment activities one can check where the company is putting its cash.
  • Inflow of cash in the form of bank loans and shareholders equity, and outflow of cash because of dividend payments, share repurchase payments etc. come under financing activities. The cash generated from these activities was $27.97M for Fennec Pharma.

Key Financial Ratios For Fennec Pharma Cash Flow

Annual Cash Flow Statements For Fennec Pharmaceuticals Inc Peers

Adamis Pharma cash flow, CytoDyn cash flow, Emisphere Tech cash flow, Forward Pharma cash flow, Soligenix cash flow